欧林生物拟收购控股子公司新诺明生物15%股权

Core Viewpoint - Olin Bio (688319.SH) announced that its subsidiary, XinNuoMing Bio, will transfer a total of 15% equity held by minority shareholders, Yihua Fund and JingChuang Fund, through a public transfer at the Southwest United Property Exchange [1] Group 1: Equity Transfer Details - The company plans to acquire the total 15% equity at a price not exceeding 5% above the listed base price and not exceeding RMB 45 million through competitive bidding [1] - The acquisition includes 8.1081% equity from Yihua Fund and 6.8919% equity from JingChuang Fund [1] Group 2: Strategic Implications - The completion of this equity acquisition will enhance the company's control and management efficiency over its subsidiary [1] - This move is expected to strengthen the overall strategic synergy and resource integration of the company [1]